Mills Pharmaceuticals


Public lists: Pharma Startups (6570)

Mills Pharmaceuticals owns the worldwide rights to GALE-401 (Anagrelide CR), a patented, controlled release formulation of anagrelide for the treatment of Essential Thrombocythemia (ET). GALE-401 (Anagrelide CR) contains the active ingredient anagrelide, an FDA-approved product, which has been in use since the late 1990s for the treatment of Essential Thrombocythemia (ET). GALE-401 is a reformulated, controlled release version of anagrelide that is currently only given as an immediate release (I...Show all

Mills Pharmaceuticals owns the worldwide rights to GALE-401 (Anagrelide CR), a patented, controlled release formulation of anagrelide for the treatment of Essential Thrombocythemia (ET). GALE-401 (Anagrelide CR) contains the active ingredient anagrel...Show all

Company (Acquired)

Phone:

Fax:




United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Mills Pharmaceuticals $0M Jan 13, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Mills Pharmaceuticals Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Partition system Jul 14, 2011 May 20, 2014 Patent
Door Apr 17, 2012 Oct 23, 2012 Patent
Pilaster for a partition system May 25, 2010 Jul 24, 2012 Patent
Storage unit Apr 16, 2010 Feb 14, 2012 Patent
Partition system Jul 02, 2008 Aug 02, 2011 Patent
See all 10 patents